Amrize (NYSE:AMRZ) Stock Price Target Lowered at Wells Fargo & Company

Amrize (NYSE:AMRZ) had its price objective lowered by stock analysts at Wells Fargo & Company from $40.00 to $39.00 in a report issued on Friday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective suggests a potential downside of 4.92% from the stock’s current price.

AMRZ has been the subject of several other reports. Citigroup lowered their target price on shares of Amrize from $58.00 to $50.00 and set a “buy” rating for the company in a research note on Friday, October 2nd. Barclays lowered their price objective on Amrize from $55.00 to $40.00 and set an “equal weight” rating for the company in a research report on Monday, October 19th. Longbow Research assumed coverage on Amrize in a research note on Monday, October 12th. They set a “buy” rating on the stock. UBS Group reduced their target price on Amrize from $57.00 to $42.00 and set a “neutral” rating on the stock in a research report on Tuesday, September 22nd. Finally, JPMorgan Chase & Co. decreased their price target on Amrize from $52.00 to $48.00 and set a “neutral” rating for the company in a research note on Tuesday, October 13th. Eight investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, Amrize currently has a consensus rating of “Hold” and an average target price of $49.24.

Amrize Stock Down 1.4%

Shares of AMRZ traded down $0.59 during mid-day trading on Friday, hitting $41.02. The company’s stock had a trading volume of 2,579,680 shares, compared to its average volume of 3,436,898. The firm has a market capitalization of $22.69 billion, a price-to-earnings ratio of 18.57, a PEG ratio of 1.42 and a beta of 0.20. Amrize has a 52-week low of $35.78 and a 52-week high of $65.94. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The company’s 50-day moving average is $39.79 and its 200-day moving average is $50.68.

Amrize (NYSE:AMRZ) last announced its earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting analysts’ consensus estimates of $1.05. The business had revenue of $3.77 billion during the quarter. Amrize had a net margin of 9.93% and a return on equity of 9.96%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.98 earnings per share. On average, equities research analysts forecast that Amrize will post 2.44 EPS for the current fiscal year.

Insider Activity

In other Amrize news, insider Mario Gross acquired 3,568 shares of the company’s stock in a transaction on Tuesday, August 11th. The shares were bought at an average cost of $46.60 per share, with a total value of $166,268.80. Following the completion of the acquisition, the insider owned 38,485 shares in the company, valued at approximately $1,793,401. This trade represents a 10.22% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jaime Hill bought 1,500 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were acquired at an average price of $47.12 per share, for a total transaction of $70,680.00. Following the transaction, the insider directly owned 29,698 shares in the company, valued at approximately $1,399,369.76. This represents a 5.32% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 48,983 shares of company stock valued at $2,158,755 over the last 90 days. Company insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. purchased a new position in Amrize in the 3rd quarter valued at about $49,000. Continuum Advisory LLC purchased a new stake in Amrize during the 2nd quarter worth approximately $62,000. IFP Advisors Inc raised its holdings in shares of Amrize by 1,707.3% during the third quarter. IFP Advisors Inc now owns 1,988 shares of the company’s stock valued at $74,000 after acquiring an additional 1,878 shares during the last quarter. NewEdge Advisors LLC raised its holdings in shares of Amrize by 1,419.7% during the second quarter. NewEdge Advisors LLC now owns 2,082 shares of the company’s stock valued at $111,000 after acquiring an additional 1,945 shares during the last quarter. Finally, Oslo Pensjonsforsikring AS acquired a new position in shares of Amrize during the first quarter valued at approximately $133,000.

About Amrize

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.